top of page
Search
Writer's pictureMiraal Mavalvala

** Updates to our COVID-19 management guidelines **

In anticipation of a possible surge in hospitalizations and taking into account recent evidence, (and limited supplies of some therapeutics) we are delighted to present our revised (v9) guidelines! Main changes compared to previous version are highlighted in "SUMMARY of changes" . As always, these guidelines are the product of thoughtful discussions between ID and pharmacy experts, with input from a multidisciplinary group of colleagues.


HAPPY HOLIDAY SEASON to all, from the ASP team!!



115 views0 comments

Recent Posts

See All

MUHC ASP annual report 2022-2023

The ASP chairs are happy to publish the MUHC ASP annual report 2022-2023, now available in the Resources section of the MUHC ASP website....

S.aureus bacteremia

The ASP committee is happy to give you an early Christmas gift! We published the guidelines on management and treatment of Staphylococcus...

Occupational exposure prophylaxy guidelines

ASP committee developed a post-exposure prophylaxis (HIV, hepB & hepC) guidelines in collaboration with the CVIS team. It is available on...

Commentaires


bottom of page